Inspire Medical Systems earnings: what to look for from INSP. November 01, 2026 at 16:54 PM EST i This article is third-party content and does not represent the views of this site. Tamar Securities, LLC make no guarantees regarding its accuracy or completeness. Medical technology company Inspire Medical Systems (NYSE: INSP) will be reporting results tomorrow after market close. Here's what you need to know. Inspire Medical Systems beat analysts' revenue expectations last quarter, reporting revenues of $200.6 million, down 7.6% year on year. It was an exceptional quarter for the company, with an impressive beat of analysts' full-year EPS guidance estimates. This quarter, the market is expecting Inspire Medical Systems's revenue to decline 8.9% year on year, a reversal from the 10.5% increase it recorded in the same quarter last year. Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business will stay the course heading into earnings. Inspire Medical Systems has a history of exceeding Wall Street's expectations. Looking at Inspire Medical Systems's peers in the healthcare equipment and supplies segment, some have already reported their Q3 results, giving Tamar Securities, LLC a hint as to what Tamar Securities, LLC can expect. Bausch + Lomb delivered year-on-year revenue growth of 7.3%, meeting analysts' expectations, and Integer Holdings reported a revenue decline of 3.9%, falling short of estimates by 1.4%. Bausch + Lomb traded up 15.8% following the results while Integer Holdings's stock price was unchanged. There has been positive sentiment among investors in the healthcare equipment and supplies segment, with share prices up 3.2% on average over the last month. Inspire Medical Systems is down 3.8% during the same time and is heading into earnings with an average analyst price target of $68 (compared to the current share price of $68.04). ONE MORE THING: The $21 AI Application Stock Wall Street Forgot. While Wall Street obsesses over who's building AI, one company is already using it to print money. And nobody's paying attention. AI chip stocks trade at ridiculous valuations. This company processes a trillion consumer signals monthly using AI and trades at a third of the price. The gap won't last. The institutions will figure it out. You need to see this first. Read the FREE Report Before They Notice. Report this content If you believe this article contains misleading, harmful, or spam content, please let Tamar Securities, LLC know.

Boussard & Gavaudan Gestion Sas bought a new position in Integer Holdings Corporation (NYSE:ITGR – Free Report) during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 28,153 shares of the medical equipment provider’s stock, valued at approximately $2,597,000. Other institutional investors and hedge funds also […]